Lantheus Medical Imaging (NSDQ:LNTH) parent company Lantheus Holdings announced the completion of its merger with Progenics Pharmaceuticals. Progenics, an oncology company developing medicines and artificial intelligence-based technologies for finding, fighting and following cancer, entered into a merger agreement with Lantheus that was first announced on Oct. 2, 2019. Upon the completion of the merger, Progenics stockholders […]
MedTech 100 roundup: Another rebound as markets continue to fluctuate
Medtech stocks rebounded from a significant dip earlier in June last week, continuing to highlight the topsy-turvy nature of the markets during the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 85.00 points at the end of last week (June 19). That total represents […]
CryoLife prices $100m offering
CryoLife Inc. (NYSE:CRY) announced today that it priced its previously announced offering of convertible senior notes at $100 million. Yesterday, the Atlanta-based company said it is offering the 4.25% notes, due in 2025, as well as a 13-day option for the initial purchaser to buy up to an additional $15 million in notes, which will be […]
Inspire Medical wins coverage from Cigna
Inspire Medical Systems (NYSE:INSP) has announced that Cigna will provide insurance coverage for the company’s Inspire obstructive sleep apnea therapy beginning this week. Cigna insures approximately 16 million members in the U.S., the minimally invasive sleep apnea treatment developer noted. The addition of Cigna brings the total of insurance policies covering Inspire to 54, representing over […]
CEO Kevin Lobo says Stryker ready to regain lost momentum
Stryker (NYSE:SYK) CEO Kevin Lobo said today that the company is preparing to restart “a number” of idled production lines next month as it climbs out the crater created by COVID-19. In an interview on the DeviceTalks Weekly Podcast, Lobo said the company is rebounding from its low point in April, when its sales fell almost […]
Second Sight Medical schedules auction of its assets
The assets of Second Sight Medical (NSDQ:EYES) are going up for auction on June 25. The developer and manufacturer of implantable visual prosthetics for blind individuals created the only FDA-approved implantable visual prosthetic treatment for severe retinitis pigmentosa. The company said in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. […]
BioCardia announces $11.5m offering
Heart failure therapy developer BioCardia (OTC:BCDA) announced that it is offering shares of common stock worth $11.5 million. The San Carlos, Calif.-based company is offering nearly 2.9 million shares of its common stock at a $0.001 par value per share. It is also offering an opportunity for certain purchasers whose purchase would otherwise result in it […]
Moody’s lowers its medical device industry earnings forecast
Medical device industry earnings will remain flat over the next 12 to 18 months as people hold off on medical procedures amid the COVID-19 pandemic and resulting recession, according to a new report from Moody’s. Moody’s had previously projected of 2–4% annual growth. “While underlying positive trends remain, including ongoing innovation and favorable longterm demographics, […]
3M announces sizable sales dips in May
3M (NYSE:MMM) announced today that it experienced a -20% sales decline year-over-year for the month of May as the COVID-19 pandemic continues to impact business. The St. Paul, Minn.-based company’s 20% dip brought sales down to $2.2 billion, with organic local-currency sales dropping -21%, although acquisitions and net of divestitures increased sales by 2%. Foreign currency […]
MedTech 100 roundup: Markets skid after strong stretch
Following a strong performance over the last couple of weeks, the medtech market experienced one of its most significant drop-offs in recent months amid investor worries over a rise in COVID-19 cases in some states. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.12 points at […]
Abbott declares 386th consecutive quarterly dividend
Abbott (NYSE:ABT) announced today that it has declared a quarterly common dividend of 36¢ per share. The Abbott Park, Ill.-based company said in a news release that the declaration marks the 386th consecutive quarterly dividend paid by the company since 1924. The dividend is payable on Aug. 17, 2020, to shareholders of record at the close […]
